Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S B Kaye

Showing results (1-10 of 411) with videos related to

Pageof 42
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 8, 2001
The integration of docetaxel into first-line chemotherapy for ovarian cancerS B Kaye,
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 10, 2001
Intravenous chemotherapy for ovarian cancer - the state of the art?S. B. Kaye
Anti-Cancer Drugs|January 12, 2000
Progress in the treatment of ovarian cancer. Scottish Gynaecological Cancer Trials GroupS B Kaye
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Chemotherapy for ovarian cancerS B Kaye
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1993
Antiemetic therapy--where do we go from here?S B Kaye
Cancer Treatment Reviews|December 1, 1990
Reversal of multidrug resistanceS B Kaye
Journal of the Royal College of Physicians of London|July 1, 1992
So, what is a clinical oncologist?S B Kaye
Seminars in Oncology|April 1, 1995
Docetaxel (Taxotere) in the treatment of solid tumors other than breast and lung cancerS B Kaye
British Medical Journal (Clinical Research Ed.)|February 12, 1983
Pneumocystis pneumoniaS B Kaye
British Journal of Cancer|August 26, 1998
New antimetabolites in cancer chemotherapy and their clinical impactS B Kaye
Pageof 42

Showing results (1-10 of 411) with videos related to

Sort By:
Pageof 42
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 8, 2001
The integration of docetaxel into first-line chemotherapy for ovarian cancerS B Kaye,
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 10, 2001
Intravenous chemotherapy for ovarian cancer - the state of the art?S. B. Kaye
Anti-Cancer Drugs|January 12, 2000
Progress in the treatment of ovarian cancer. Scottish Gynaecological Cancer Trials GroupS B Kaye
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Chemotherapy for ovarian cancerS B Kaye
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1993
Antiemetic therapy--where do we go from here?S B Kaye
Cancer Treatment Reviews|December 1, 1990
Reversal of multidrug resistanceS B Kaye
Journal of the Royal College of Physicians of London|July 1, 1992
So, what is a clinical oncologist?S B Kaye
Seminars in Oncology|April 1, 1995
Docetaxel (Taxotere) in the treatment of solid tumors other than breast and lung cancerS B Kaye
British Medical Journal (Clinical Research Ed.)|February 12, 1983
Pneumocystis pneumoniaS B Kaye
British Journal of Cancer|August 26, 1998
New antimetabolites in cancer chemotherapy and their clinical impactS B Kaye
Pageof 42